Electric Scooter (FDB08, FDB08A, FDB12)
Anhui JBH Medical Apparatus Co., Ltd. · Decision date Sep 19, 2026
What did the FDA decide?
FDA recorded a substantial equivalence (SESE) decision for K261859 on September 19, 2026, covering the Electric Scooter models FDB08, FDB08A and FDB12 from Anhui JBH Medical Apparatus Co., Ltd. The devices are Class II motorized three-wheeled vehicles under 21 CFR 890.3800, product code INI, in the Physical Medicine specialty. The submission, dated and received August 20, 2026, cites predicate K242387, a Mobility Scooter (model N3473) from Zhejiang Innuovo Rehabilitation Devices Co., Ltd.
The summary describes four-wheel scooters with aluminium alloy frames, tiller control levers, electromagnetic brakes and lithium-ion batteries; the models differ in motor power (300W, 400W, 500W), battery capacity and, for FDB12, a 150 kg load rating and adjustable suspended seat. The summary lists differences from the predicate in incline, turning radius and obstacle climbing, and states testing followed ISO 7176 series standards and EN 12184:2022. The clearance letter does not establish clinical superiority, and the source does not provide the full test results.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Physical Medicine
- Decision date
- Sep 19, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261859
- Regulatory pathway
- 510(k) premarket notification
- Product code
- INI
- Decision code
- SESE
- Decision date
- Sep 19, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Vehicle, Motorized 3-Wheeled.
- Product code
- INI
- FDA device class
- 2
FDA decision timeline
K261859 received
Application receipt date recorded by FDA.
K261859 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code INI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Nanjing Mijo Technology Co., Ltd. | 510(k) clearance | Sep 29, 2026 | FDA | |
| Zhejiang Kailang Technology Co., Ltd. | 510(k) clearance | Sep 29, 2026 | FDA | |
| Anhui JBH Medical Apparatus Co., Ltd. | 510(k) clearance | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Anhui JBH Medical Apparatus Co., Ltd.
- Headquarters
- Not reported
- Brand website
- jbhmedical.com
- FDA applicant address
- Chuzhou
Sources and methodology
- Original FDA record: K261859
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

